Alpha Cognition Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Grapevine, TX
ACOG chart
What traders are saying about $ACOG
Latest postsAlpha Cognition Inc. news
- Form 4 Alpha Cognition Inc.: Opaleye Management Inc. (10% Owner) For: 22 October By Investing.com
Investing.com South Africa ·
- Opaleye Management Acquires 32,090 Shares of Alpha Cognition Over Two Days
Kalkine Media ·
- A 10% owner's fund buys Alpha Cognition (ACOG) shares at weighted average prices of $8.3266 and $8.2344.
Stock Titan ·
- Alpha Cognition Inc. Estimates – NASDAQ:ACOG
TradingView ·
- Alpha Cognition Inc. Common Stock (ACOG) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?
Yahoo Finance ·
- Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
Yahoo Finance ·
- Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
Yahoo Finance ·
- Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
Yahoo Finance ·
- Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
Yahoo Finance ·
- Alpha Cognition (ACOG) Stock Fair Value Rises After Zunveyl Analyst Optimism
Yahoo Finance ·
Alpha Cognition Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $10.2M | – | – |
| Net income | -$20.7M | -$14.8M | -$13.8M |
| Diluted EPS | $-1.18 | $-2.04 | $-3.84 |
| Total assets (year end) | $79.7M | $50.7M | $2.5M |
| Cash and equivalents (year end) | $66.0M | $48.5M | $1.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-K/AFORM 8-K/A
- DEF 14ADEFINITIVE PROXY STATEMENT
- 8-KFORM 8-K
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
About Alpha Cognition Inc.
- Ticker
- ACOG (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Grapevine, TX
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1655923
- Former names
- Neurodyn Cognition Inc.
Frequently asked questions
What exchange is Alpha Cognition Inc. listed on?
Alpha Cognition Inc. trades on the Nasdaq under the ticker symbol ACOG.
What industry is Alpha Cognition Inc. in?
Alpha Cognition Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Alpha Cognition Inc. headquartered?
Alpha Cognition Inc.'s business address on file with the SEC is in Grapevine, TX.
When does Alpha Cognition Inc.'s fiscal year end?
Alpha Cognition Inc.'s fiscal year ends on December 31.
How much revenue did Alpha Cognition Inc. report?
Alpha Cognition Inc. reported $10.2M in revenue for calendar year 2025, according to its SEC filings.